Hikma and FAES Farma enter into exclusive licensing agreement for the commercialisation of Bilastine tablets in the US Read more
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS) Read more
Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference Read more
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics Read more
Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets Read more